Asthma is the most common chronic disease of childhood. Center research has focused on understanding disparities in asthma and improving adherence to needed medications. Specific studies include:
The Population-Based Effectiveness in Asthma and Lung Diseases (PEAL) Network, a six-center collaborative that conducts comparative effectiveness and aherence research. The network is designed to support future work in pharmacogenetics and delivery science.
Related News and Recent Publications
- Trivedi M, Fung V, Kharbanda EO, et al. Racial disparities in family-provider interactions for pediatric asthma care. Journal of Asthma. 2017:1-6.
- Wu AC, Li L, Fung V, et al. Mismatching Among Guidelines, Providers, and Parents on Controller Medication Use in Children with Asthma. The Journal of Allergy and Clinical Immunology: In Practice. 2016/09/01/ 2016;4(5):910-916.
- Holder-Niles F, Haynes L, D’Couto H, et al. Coordinated Asthma Program Improves Asthma Outcomes in High-Risk Children. Clinical pediatrics. 2017/09/01 2017;56(10):934-941.
- Kelly RS, Dahlin A, McGeachie MJ, et al. Asthma Metabolomics and the Potential for Integrative Omics in Research and the Clinic. CHEST.151(2):262-277.
- Wu AC, Gay C, Rett MD, Stout N, Weiss ST, Fuhlbrigge AL. Pharmacogenomic test that predicts response to inhaled corticosteroids in adults with asthma likely to be cost-saving. Pharmacogenomics. 2015;16(6):591-600.
- Wu AC, Butler MG, Li L, Fung V, Kharbanda EO, Larkin EK, Vollmer WM, Miroshnik I, Davis RL, Lieu TA, Soumerai SB. Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc. 2015 Feb;12(2):161-6.
For more information on the Center's work please contact Kelly Horan